Vivo Capital Surplus Fund VIII is a Venture Capital Fund in California, that has raised $750.00 mm from 56 investors, for a fund started in Dec 2014. Data from SEC filing on 17 Mar 2015.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
AUM ?
$124.89 mm
Address
Vivo Capital Surplus Fund VIII
505 HAMILTON AVENUE, SUITE 200
PALO ALTO
CA 94301
505 HAMILTON AVENUE, SUITE 200
PALO ALTO
CA 94301
Phone
650 688 0818
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Vivo Capital, LLC | $5.42 bn | |
Vivo Asia Opportunity Fund Holdings, L.P. | $158.00 mm | Other Private Fund |
Vivo Asia Opportunity Fund Associates, L.P. | ||
Vivo Asia Opportunity Fund, L.P. | ||
Vivo Capital Fund IX, L.P. | $2.84 bn | Private Equity Fund |
Vivo Capital Fund VIII, L.P. | $905.00 mm | Private Equity Fund |
Vivo Capital Surplus Fund VIII, L.P. | $124.89 mm | Private Equity Fund |
Vivo Co-invest (S), L.P. | $50.00 mm | Venture Capital Fund |
Vivo Innovation Fund II Holdings, L.P | $362.55 mm | Venture Capital Fund |
Vivo Innovation Fund II, L.P. | ||
Vivo Innovation Fund II Associates, L.P. | ||
Vivo Opportunity Co-invest, L.P. | $68.09 mm | Other Private Fund |
Vivo Opportunity Fund Holdings, L.P. | $661.40 mm | Other Private Fund |
Vivo Opportunity Fund, L.P. | ||
Vivo Opportunity Fund Associates, L.P. | ||
Vivo Panda Fund, LP | $82.81 mm | Venture Capital Fund |
Vivo Super VIII Limited | $355.43 mm | Venture Capital Fund |
Vivo Ventures Fund Cayman VII, LP | $53.22 mm | Venture Capital Fund |
Vivo Ventures Fund VI, LP | $4.81 mm | Venture Capital Fund |
Vivo Ventures Fund VII, LP | $79.22 mm | Venture Capital Fund |
Vivo Ventures VI Affiliates Fund, LP | $100.07 k | Venture Capital Fund |
Vivo Ventures VII Affiliates Fund, LP | $1.84 mm | Venture Capital Fund |
Latest ownership filings
4
Terns Pharmaceuticals, Inc.
3 Apr 24
144
Terns Pharmaceuticals, Inc.
3 Apr 24
144
Terns Pharmaceuticals, Inc.
1 Apr 24
4
IMPEL PHARMACEUTICALS INC
19 Dec 23
4
Bolt Biotherapeutics, Inc.
22 Nov 23
4
Bolt Biotherapeutics, Inc.
20 Nov 23
4
Terns Pharmaceuticals, Inc.
23 Dec 22
4
Terns Pharmaceuticals, Inc.
8 Sep 22
4
Terns Pharmaceuticals, Inc.
16 Aug 22
4
IMPEL NEUROPHARMA INC
29 Apr 21